Clot-Targeted Antithrombotic Liposomal Nanomedicine Containing High Content of H2O2-Activatable Hybrid Prodrugs
- 7 February 2023
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Applied Materials & Interfaces
- Vol. 15 (7) , 8999-9009
Abstract
Liposomes have been extensively explored as drug carriers, but their clinical translation has been hampered by their low drug-loading content and premature leakage of drug payloads. It was reasoned that vesicle-forming prodrugs could be incorporated into the lipid bilayer at a high molar fraction and therefore serve as a therapeutic agent as well as a structural component in liposomal nanomedicine. Boronated retinoic acid (BORA) was developed as a prodrug, which can self-assemble with common lipids to form liposomes at a high molar fraction (40%) and release all-trans retinoic acid (atRA) and hydroxybenzyl alcohol (HBA) simultaneously, in response to hydrogen peroxide (H2O2). Here, we report fucoidan-coated BORA-incorporated liposomes (f-BORALP) as clot-targeted antithrombotic liposomal nanomedicine with H2O2-triggered multiple therapeutic actions. In the mouse model of carotid arterial thrombosis, f-BORALP preferentially accumulated in the injured blood vessel and significantly suppressed thrombus formation, demonstrating their potential as targeted antithrombotic nanomedicine. This study also provides valuable insight into the development of vesicle-forming and self-immolative prodrugs to exploit the benefits of liposomal drug delivery.Keywords
Funding Information
- National Research Foundation of Korea (2020R1A4A200281711, 2021R1A2C1003204)
This publication has 52 references indexed in Scilit:
- Comparison of the effect of coagulation and platelet function impairments on various mouse bleeding modelsThrombosis and Haemostasis, 2014
- Remote loading of preencapsulated drugs into stealth liposomesProceedings of the National Academy of Sciences, 2014
- Antioxidant potential of all- trans retinoic acid (ATRA) and enhanced activity of liposome encapsulated ATRA against inflammation and tumor-directed angiogenesisImmunopharmacology and Immunotoxicology, 2012
- Retinoids, Retinoic Acid Receptors, and CancerAnnual Review of Pathology: Mechanisms of Disease, 2011
- Antioxidant and Anti-Inflammatory Activities of Hydroxybenzyl Alcohol Releasing Biodegradable Polyoxalate NanoparticlesBiomacromolecules, 2010
- Liposomal Formulation of Retinoids Designed for Enzyme Triggered ReleaseJournal of Medicinal Chemistry, 2010
- The Surgeon General’s Call to Action to Prevent Deep Vein Thrombosis and Pulmonary EmbolismCirculation, 2009
- Biodistribution characteristics of all-trans retinoic acid incorporated in liposomes and polymeric micelles following intravenous administrationJournal of Pharmaceutical Sciences, 2005
- Rapid improvement of coagulopathy by all‐trans retinoic acid in acute promyelocytic leukemiaAmerican Journal of Hematology, 1994
- Solubility of retinoids in waterArchives of Biochemistry and Biophysics, 1991